Replidyne, a successful biopharmaceutical company has chosen Baker Communications to provide presentations training to their market researchers. The Exceptional Presentations course will give market researchers critical skills such as the Power Position, the Four Ps, and handling objections. During the training, participants will learn how to fully prepare, and then deliver, effective presentations by working with senior instructors to evaluate themselves through the use of video taped sessions. The interactive nature of the Exceptional Presentations workshop will empower participants to deliver presentations with confidence and success.

Senior level Baker instructors will arrive in Broomfield, Colorado to engage Replidyne market researchers. Replidyne selected Baker Communications for Baker’s commitment to Replidyne’s special needs, as well as for Baker’s ability to fully tailor the Exceptional Presentations training to completely meet those needs.

About Baker Communications

Since 1979, Baker Communications has aided hundreds of thousands of individuals in reaching their maximum performance potential in the workplace through corporate training. Globally-recognized companies, associations, non-profit organizations, and government agencies such as Dell, Bank of America, and ExxonMobil have depended on Baker Communications to act as a valued training provider to equip their employees with the skills that produce results in the field as well as the office. Baker Communications’ materials have been utilized and delivered worldwide throughout Europe, South America, North America, the Middle East, and Asia Pacific. Classes are held publicly throughout the United States and Canada in over twenty cities or delivered privately on-site at client-designated locations.

About Replidyne

Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products. Founded in 2000, Replidyne is headquartered in Louisville, Colorado and maintains a strong focus on discovery research. All research and development, manufacturing, business development, commercial and operational functions operate out of Colorado, while Replidyne’s clinical and regulatory development group is based in Milford, Connecticut. The team’s depth of professional experience in drug development, especially in the area of anti-infective products, positions Replidyne to quickly and successfully meet the current challenges of anti-infective drug development.